- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05140109
Trial on Three Eating Disorders Group Treatment
17. november 2021 oppdatert av: Roxane Turgon, University Grenoble Alps
Effectiveness Randomized Controlled Trial on Eating Disorders Group Treatment: a Cognitive Dissonance, a Mindfulness and a Person-centered Based Program
This trial aims at comparing three group treatments designed for eating disorders: a Cognitive-dissonance, a Mindfulness and a Person-centered based programs.
Women with eating disorders will be recruited and randomized to one of the three programs.
Participants will complete a pretest, a posttest, a 3-months follow-up and a 1-year follow-up.
This trial aims to compare the programs to analyze the specific dimensions upon which each program acts.
The investigators therefore made hypotheses according to the programs' theory: participants in the Cognitive-dissonance based program should experience a greater decrease in eating disorders symptoms, thin-ideal internalization and body dissatisfaction and a greater improvement in quality of life than other participants.
Participants in the Mindfulness-based program should show a greater improvement in negative affect and in equanimity than other participants.
Participants in the Person-Centered based program should report a greater increase in congruence than other participants.
Studieoversikt
Status
Aktiv, ikke rekrutterende
Forhold
Studietype
Intervensjonell
Registrering (Faktiske)
100
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Paris, Frankrike, 75015
- Association Endat
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Hunn
Beskrivelse
Inclusion Criteria:
- eating disorders (anorexia nervosa, bulimia nervosa or binge eating disorder) or other specified feeding or eating disorder (subthreshold of anorexia, bulimia or binge eating disorder) according to Diagnostic Statistical Manual 5
- to have no regular treatment (no more than one session per month) during the 8 weeks of the program
- participants with a Body Mass Index under 17.5 could be include in the study if they had a medical monitoring in another structure
Exclusion Criteria:
- a psychotic disorder
- a bipolar disorder
- a mental retardation
- to not read or speak French fluently
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Cognitive-dissonance based program
Group program of 8 sessions of one hour and a half.
|
The first four sessions focus on body image and the last four sessions on eating behavior.
|
Aktiv komparator: Mindfulness-based program
Group program of 8 sessions of one hour and a half.
|
The sessions focus on different contents as body image, eating behavior and emotion regulation.
|
Aktiv komparator: Person-centered program
Group program of 8 sessions of one hour and a half.
|
The sessions are not structured.
Participants can bring any subject they need to talk.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Mean change in The Eating Disorders Diagnostic Interview from pretest to 1-year follow-up
Tidsramme: From pretest to 1-year follow-up
|
The minimum of the scale is 0 and the maximum is 276.
A higher score means a worse outcome.
|
From pretest to 1-year follow-up
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Mean change in The Hospital Anxiety and Depression Scale from pretest to 1-year follow-up
Tidsramme: From pretest to 1-year follow-up
|
The minimum of the scale is 0 and the maximum is 42.
A higher score means a worse outcome.
|
From pretest to 1-year follow-up
|
Mean change in the subscale "Body dissatisfaction" from the scale Eating disorders inventory-2 from pretest to 1-year follow-up
Tidsramme: From pretest to 1-year follow-up
|
The minimum of the scale is 0 and the maximum is 27.
A higher score means a worse outcome.
|
From pretest to 1-year follow-up
|
Mean change in the Sociocultural Attitudes Towards Appearance Scale from pretest to 1-year follow-up
Tidsramme: From pretest to 1-year follow-up
|
The minimum of the scale is 0 and the maximum is 150.
A higher score means a worse outcome.
|
From pretest to 1-year follow-up
|
Mean change in the World Health Organization Quality Of Life Scale from pretest to 1-year follow-up
Tidsramme: From pretest to 1-year follow-up
|
The minimum of the scale is 0 and the maximum is 20.
A higher score means a better outcome.
|
From pretest to 1-year follow-up
|
Mean change in the Strathclyde Inventory measuring congruence from pretest to 1-year follow-up
Tidsramme: From pretest to 1-year follow-up
|
The minimum of the scale is 0 and the maximum is 4. A higher score means a better outcome.
|
From pretest to 1-year follow-up
|
Mean change in the Equanimity scale from pretest to 1-year follow-up
Tidsramme: From pretest to 1-year follow-up
|
The minimum of the scale is 0 and the maximum is 7.
A higher score means a better outcome.
|
From pretest to 1-year follow-up
|
Andre resultatmål
Resultatmål |
Tidsramme |
---|---|
Presence or absence of ancillary treatment at 3-months follow-up
Tidsramme: At 3-months follow-up
|
At 3-months follow-up
|
Demographic data (age) at pretest
Tidsramme: At pretest
|
At pretest
|
Demographic data (socio-professional status) at pretest
Tidsramme: At pretest
|
At pretest
|
Demographic data (marital status) at pretest
Tidsramme: At pretest
|
At pretest
|
Demographic data (education level) at pretest
Tidsramme: At pretest
|
At pretest
|
Demographic data (Body Mass Index) at pretest
Tidsramme: At pretest
|
At pretest
|
Demographic data (duration of eating disorders symptoms) at pretest
Tidsramme: At pretest
|
At pretest
|
Demographic data (treatment medical history for eating disorders symptoms) at pretest
Tidsramme: At pretest
|
At pretest
|
Demographic data (traumatic medical history) at pretest
Tidsramme: At pretest
|
At pretest
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Roxane Turgon, Université Grenoble-Alpes
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
1. september 2018
Primær fullføring (Faktiske)
29. januar 2021
Studiet fullført (Forventet)
22. september 2022
Datoer for studieregistrering
Først innsendt
5. november 2021
Først innsendt som oppfylte QC-kriteriene
17. november 2021
Først lagt ut (Faktiske)
1. desember 2021
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
1. desember 2021
Siste oppdatering sendt inn som oppfylte QC-kriteriene
17. november 2021
Sist bekreftet
1. november 2021
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2020-A02346-33a
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Nei
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Spiseforstyrrelser
-
Western University, CanadaHar ikke rekruttert ennåeTRE (Early Time Restricted Eating) med BCAA | eTRE (Early Time Restricted Eating)Canada
-
Western University, CanadaUkjenteTRE (Early Time Restricted Eating) | lTRE (Late Time Restricted Eating)Canada
-
Western University, CanadaHar ikke rekruttert ennåeTRE (Early Time Restricted Eating) | eTRE med BISC (Kort intens trappeklatring)Canada
-
Marianne Lau, MD, DSci.The Ministry of Science, Technology and Innovation, DenmarkUkjentBulimia Nervosa (BN) | Binge Eating Disorder (BED) | Spiseforstyrrelse ikke spesifisert på annen måte (EDNOS)Danmark
-
SunovionFullførtAttention Deficit Hyperactivity Disorder (ADHD) | Binge-Eating Disorder DisorderForente stater
Kliniske studier på Arm 1: Cognitive-dissonance based program
-
The Lymphoma Academic Research OrganisationRekrutteringMarginal sone lymfomFrankrike
-
Children's Oncology GroupRekrutteringAkutt myeloid leukemi | Akutt lymfatisk leukemi | Myelodysplastisk syndrom | Blandet fenotype akutt leukemiForente stater, Australia, Canada